Drug
Imeglimin clinical trials
- studies test it
- 9
- open now
- 1
- in phase 3
- 0
- first study started
- 2013
Keep track of what changes. Save the imeglimin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
9 studies that test it; most in 2018 (3)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 3 |
| 2022 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 6
- Phase 2
- 1
- Phase 4
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 2
Poxel SA (6) · National Center for Global Health and Medicine, Japan (1) · Humanis Saglık Anonim Sirketi (1) · Mansoura University (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses imeglimin is read from its arms, and is right about nine times in ten.
Testing it · 9
- Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin MonotherapyNot yet recruitingPhase 4Mansoura UniversityNCT07436182Written as Imeglimin
- Bioequivalence Study to Compare Imeglimin HCl 500 mg Film Coated Tablets Versus Twymeeg Tablets 500 mgCompletedPhase 1Humanis Saglık Anonim SirketiNCT07691177Written as Imeglimin Hydrochloride Film Coated Tablet
- Durable Effect of Imeglimin on the Glycemic Control in Patients With Type 2 Diabetes MellitusActive, not recruitingPhase 4National Center for Global Health and Medicine, JapanNCT05366868Written as Imeglimin
- Pharmacokinetics of Imeglimin in Hepatic Impaired SubjectsCompletedPhase 1Poxel SANCT03802786Written as Imeglimin
- Bioequivalence of Imeglimin Tablet FormulationsCompletedPhase 1Poxel SANCT03646331Written as Imeglimin
- Effect of Cimetidine on the PK of ImegliminCompletedPhase 1Poxel SANCT03618316Written as Imeglimin
- Safety, Tolerability and PK of Imeglimin in Japanese VolunteersCompletedPhase 1Poxel SANCT02373150Written as Imeglimin
- Effect of Imeglimin on QT/QTc Intervals in Healthy SubjectsCompletedPhase 1Poxel SANCT02924337Written as Imeglimin
- A Study of the Efficacy and Safety of 4 Doses of Imeglimin After 24 Weeks of Treatment in Subjects With Type 2 DiabetesCompletedPhase 2Poxel SANCT01951235Written as Imeglimin
Codes
What other systems call imeglimin · ClinicalTrials.gg INT006163
- MeSH (NLM) C575881imegliminConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) UU226QGU97IMEGLIMINConfirmed FDA, NLM, Wikidata
- Wikidata Q6003719imegliminConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C132841ImegliminOne source FDA
- DrugBank DB12509One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C575881 | imeglimin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | UU226QGU97 | IMEGLIMIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q6003719 | imeglimin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C132841 | Imeglimin | One source FDA |
| DrugBank | DB12509 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.